Puma Biotechnology Announces Positive Top Line Results From Phase III PB272 Trial In Adjuvant Breast Cancer
July 22, 2014 at 16:20 PM EDT
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced top line results from the Phase III ...